Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
A common GWAS variant associated with vitamin D levels38 maps to a disordered region of an unannotated FOXO6 isoform (Fig.
Source: Disease-associated variants in tissue-specific alternative isoforms. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Laboratory / cell research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Human cell line and tissue data for each protein sequence were amalgamated into tissue types.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Disease-associated genetic variants can cause missense effects in tissue-specific protein isoforms
Study design awaiting verification · Nature Communications · 2026
Original publication title
Disease-associated genetic variants can cause missense effects in tissue-specific protein isoforms
© The Author(s) 2026
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Genetic variants can cause protein-coding mutations that result in disease. Variants are typically interpreted using the reference transcript for a gene. However, most human multi-exon genes have alternative isoforms. We show that, consistent with their reduced evolutionary constraint, coding exons in alternative isoforms harbour more population variants than exons of reference isoforms, and that these variants are more likely to cause nonsynonymous mutations. Common and rare disease-associated variants mapping to alternative transcripts can lead to amino acid substitutions predicted to be structurally damaging in the corresponding protein isoform.
The alternative transcripts to which disease-associated variants map demonstrate high tissue-specificity, with many unannotated in reference human genomes, and only revealed by long-read RNA-sequencing. As an example, we report an unannotated, alternative transcript of the inflammasome regulator DPP9 that is lung epithelium-specific, that harbours a common genetic variant associated with severe COVID-19 and lung fibrosis. Using deep RNA sequencing of full-length transcript isoforms by targeted capture, we confirm the expression of the unannotated DPP9 isoform. The DPP9 isoform variant causes a p.Leu8Pro missense mutation in an alternative first exon, predicted to disrupt the encoded alpha helix, and we show that the variant alters DPP9 enzymatic activity.
Our findings highlight the importance of considering alternative isoforms, their tissue-specific expression, and full-length transcripts in variant interpretation, with implications for uncovering underappreciated mechanisms of both common and rare disease.
Isoforms are seldom considered in genetic variant interpretation. Here the authors map common and rare variants to alternative isoforms, which can be highly expressed and tissue-specific. A common DPP9 variant maps to a lung expressed alternative isoform, with the missense variant altering activity.
Authors’ abstract
Genetic variants can cause protein-coding mutations that result in disease. Variants are typically interpreted using the reference transcript for a gene. However, most human multi-exon genes have alternative isoforms. We show that, consistent with their reduced evolutionary constraint, coding exons in alternative isoforms harbour more population variants than exons of reference isoforms, and that these variants are more likely to cause nonsynonymous mutations. Common and rare disease-associated variants mapping to alternative transcripts can lead to amino acid substitutions predicted to be structurally damaging in the corresponding protein isoform.
The alternative transcripts to which disease-associated variants map demonstrate high tissue-specificity, with many unannotated in reference human genomes, and only revealed by long-read RNA-sequencing. As an example, we report an unannotated, alternative transcript of the inflammasome regulator DPP9 that is lung epithelium-specific, that harbours a common genetic variant associated with severe COVID-19 and lung fibrosis. Using deep RNA sequencing of full-length transcript isoforms by targeted capture, we confirm the expression of the unannotated DPP9 isoform. The DPP9 isoform variant causes a p.Leu8Pro missense mutation in an alternative first exon, predicted to disrupt the encoded alpha helix, and we show that the variant alters DPP9 enzymatic activity.
Our findings highlight the importance of considering alternative isoforms, their tissue-specific expression, and full-length transcripts in variant interpretation, with implications for uncovering underappreciated mechanisms of both common and rare disease.
Isoforms are seldom considered in genetic variant interpretation. Here the authors map common and rare variants to alternative isoforms, which can be highly expressed and tissue-specific. A common DPP9 variant maps to a lung expressed alternative isoform, with the missense variant altering activity.
Publication and source details
Original title: Disease-associated genetic variants can cause missense effects in tissue-specific protein isoforms
Giovanna Weykopf; Mihaly Badonyi; Elias T. Friman; Jasmine Minh Hang Nguyen; Alexis Ioannou; Benjamin J. Livesey; Audrey Coutts; Elizabeth F. Hird; Murray Wham; Chloe M. Stanton; Veronique Vitart; Jing Su; Lee Murphy; J. Kenneth Baillie; Mark D. Gorrell; Joseph A. Marsh; Wendy A. Bickmore; Simon C. Biddie
Nature Communications · 2026
© The Author(s) 20262026https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.https://doi.org/10.13039/501100000589Chief Scientist Office (CSO)PCL/20//02Biddie Simon C. https://doi.org/10.13039/501100009187RCUK | MRC | Medical Research FoundationMC_UU_00035/7MC_UU_00035/9Biddie Simon C. https://doi.org/10.13039/100010661EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020)101001169Biddie Simon C. https://doi.org/10.13039/100004440Wellcome Trust (Wellcome)223164/Z/21/ZBiddie Simon C.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T22:18:56.393846+00:00
DOI: 10.1038/s41467-026-74280-w · PMC13429693